Transform Patient Care Through Regenerative Medicine
ACell’s platform MatriStem UBM™ technology facilitates the body’s ability to remodel functional tissue1. Our mission is to leverage that technology to help patients around the world.
We're Here to Help
As the healthcare system continues to respond to the COVID-19 pandemic, ACell remains ready to support our customers and their patients with solutions for acute soft tissue reconstruction.
Now Available: Large Area Cytal® Wound Matrix 3-Layer Devices
These new 16 x 25 cm and 16 x 35 cm sheets provide full coverage for areas of extensive tissue loss as one of the largest wound management device footprints on the market.
Explore ACell Products
Large Area Cytal® Wound Matrix 3-Layer
Now offering two larger sizes in the Cytal Wound Matrix 3-Layer product line. These additional sizes will provide larger coverage for areas with extensive tissue loss.
Gentrix® Surgical Matrix
Gentrix is a resorbable, non-crosslinked surgical device designed to strengthen and support the repair of soft tissue defects including ventral, parastomal, and hiatal hernias.
MicroMatrix is an easy to apply, fully-resorbable particulate that provides intimate contact with wounds and is ideal for irregular or tunneling wounds.
Cytal® Wound Matrix
Cytal is a highly conformable, pre-fenestrated sheet that is available in multiple sizes and thicknesses to allow for tailored wound management.
ABRA System pulls muscle planes and skin together from their lateral retracted state with dynamic appositional traction facilitating primary closure.
ACell and Southmedic Announce Canadian Launch of Gentrix Surgical Matrix Family of Products
ACell Receives Supplier Legacy Award from Premiere Inc.
Access information on product ordering, reimbursement, and professional education opportunities.
ACell is a leading regenerative medicine company that develops and manufactures products designed to facilitate the body’s ability to repair and remodel tissue.